St. Mary’s Medical Center announced that it is one of the first in South Florida to have access to the latest technology from Stryker Neurovascular for removing clots from the brain in patients experiencing acute ischemic stroke. The Trevo Pro Retriever has been granted market clearance by the FDA and is the first device to use proprietary Stentriever Technology, designed for optimized clot integration and retrieval. The first patient was successfully treated at St. Mary’s Medical Center by Interventional Neurologist Dr. Ali Malek, Medical Director of the Neurointerventional Program.
The Trevo Pro Retriever demonstrated strong clinical results in the Trevo 2 Clinical trial compared to the Merci Retriever, the previous generation of clot removal devices. This new technology has one of the highest rates of revascularization and good clinical outcomes in a randomized embolectomy stroke device trial.